Antineoplastic effects of clove buds (Syzygium aromaticum L.) in the model of breast carcinoma.

Abstract

It is supposed that plant functional foods, rich in phytochemicals, may potentially have preventive effects in carcinogenesis. In this study, the anticancer effects of cloves in the in vivo and in vitro mammary carcinoma model were assessed. Dried flower buds of cloves (CLOs) were used at two concentrations of 0.1% and 1% through diet during 13 weeks after the application of chemocarcinogen. After autopsy, histopathological and immunohistochemical analyses of rat mammary carcinomas were performed. Moreover, in vitro evaluation using MCF-7 cells was carried out. Dietary administered CLO caused the dose-dependent decrease in tumour frequency by 47.5% and 58.5% when compared to control. Analysis of carcinoma cells in animals showed bcl-2, Ki67, VEGFA, CD24 and CD44 expression decrease and Bax, caspase-3 and ALDH1 expression increase after high-dose CLO administration. MDA levels were substantially decreased in rat carcinomas in both CLO groups. The evaluation of histone modifications revealed increase in lysine trimethylations and acetylations (H4K20me3, H4K16ac) in carcinomas after CLO administration. TIMP3 promoter methylation levels of CpG3, CpG4, CpG5 islands were altered in treated cancer cells. An increase in total RASSF1A promoter methylation (three CpG sites) in CLO 1 group was found. In vitro studies showed antiproliferative and pro-apoptotic effects of CLO extract in MCF-7 cells (analyses of cytotoxicity, Brdu, cell cycle, annexin V/PI, caspase-7, Bcl-2 and mitochondrial membrane potential). This study showed a significant anticancer effect of clove buds in the mammary carcinoma model in vivo and in vitro.

• Authors: Peter Kubatka, Sona Uramova, Martin Kello, Karol Kajo, Peter Kruzliak, Jan Mojzis, Desanka Vybohova, Marian Adamkov, Karina Jasek, Zora Lasabova, Pavol Zubor, Silvia Fialova, Svetlana Dokupilova, Peter Solar, Martin Pec, Katarina Adamicova, Jan Danko, Mariusz Adamek, Dietrich Busselberg
• Journal: Journal of cellular and molecular medicine (J Cell Mol Med) Vol. 21 Issue 11 Pg. 2837-2851 (Nov 2017) ISSN: 1582-4934 [Electronic] England
• PMID: 28524540 (Publication Type: Journal Article)
• Copyright: © 2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

Chemical References

• Antineoplastic Agents, Phytogenic
• Bax protein, rat
• Bcl2 protein, rat
• Histones
• Ki-67 Antigen
• Plant Extracts
• Proto-Oncogene Proteins c-bcl-2
• RASSF1 protein, rat
• Tumor Suppressor Proteins
• Vascular Endothelial Growth Factor A
• bcl-2-Associated X Protein
• vascular endothelial growth factor A, rat
• Aldehyde Dehydrogenase 1 Family
• Aldh1a1 protein, rat
• Retinal Dehydrogenase
• Casp3 protein, rat
• Caspase 3

Topics

• Adenocarcinoma (diet therapy, genetics, metabolism, pathology)
• Aldehyde Dehydrogenase 1 Family
• Animals
• Antineoplastic Agents, Phytogenic (isolation & purification, pharmacology)
• Breast Neoplasms (diet therapy, genetics, metabolism, pathology)
• Caspase 3 (genetics, metabolism)
• DNA Methylation (drug effects)
• Dose-Response Relationship, Drug
• Epigenesis, Genetic (drug effects)
• Female
• Flowers (chemistry)
• Histones (genetics, metabolism)
• Humans
• Ki-67 Antigen (genetics, metabolism)
• MCF-7 Cells
• Mammary Neoplasms, Experimental (diet therapy, genetics, metabolism, pathology)
• Membrane Potential, Mitochondrial (drug effects)
• Plant Extracts (chemistry)
• Proto-Oncogene Proteins c-bcl-2 (genetics, metabolism)
• Rats
• Rats, Sprague-Dawley
• Retinal Dehydrogenase (genetics, metabolism)
• Signal Transduction
• Syzygium (chemistry)
• Tumor Burden (drug effects)
• Tumor Suppressor Proteins (genetics, metabolism)
• Vascular Endothelial Growth Factor A (genetics, metabolism)
• bcl-2-Associated X Protein (genetics, metabolism)